Johanne Kaplan
Chief Development OfficerDr. Johanne Kaplan, Ph.D is Member of Scientific Advisory Board of Autoimmunity Biologic Solutions Inc. She has been Chief Development Officer at ProMIS Neurosciences Inc., since July 21, 2016. Dr. Kaplan focus on supporting the design and execution of ProMIS' development programs and partnering efforts. She joined ProMIS following 24 years at Genzyme (a Sanofi company), where she held positions of increasing responsibility, culminating in her decade-long tenure as Vice President of Research, most recently directing the multiple sclerosis and neuroimmunology research effort from July 2005 to July 2015. Dr. Kaplan served as Chief Scientific Officer at Epiva since July 2015 to May 2016. Dr. Kaplan also served as Chief Scientific Officer at Shepherd Therapeutics from 2016 to 2021. Dr. Kaplan held increasing positions of responsibility at Sanofi Genzyme, from 1992 through 2015, most recently serving as Vice President of Research at Sanofi Genzyme from 2005 until her retirement in 2015. Over the course of her career at Genzyme, Dr. Kaplan directed pioneering research leading to the implementation of multiple clinical trials in the fields of gene therapy, cancer immunotherapy and autoimmunity. As Vice President of Neuroimmunology Research, Dr. Kaplan led the Genzyme science team's contribution to the approval of Lemtrada (alemtuzumab) and Aubagio (teriflunomide) for the treatment of relapsing-remitting multiple sclerosis. She also established partnerships for the development of novel therapies for neuroinflammatory disorders. Prior to joining Genzyme, Dr. Kaplan served as an Associate Immunopathologist at SmithKline Beecham where she established an Immunotoxicology program. Her work has resulted in more than 60 scientific publications and multiple patents. Dr. Kaplan holds a PhD in Microbiology and Immunology from McGill University in Montreal, Canada and conducted post-doctoral studies at the Albert Einstein College of Medicine in New York, USA.
Positions
- Company NameProMIS Neurosciences, Inc.Stock CodePMNPositionChief Development OfficerColleagues
- EWEugene W. WilliamsCo-Founder & Chairman
- NKNeil K. WarmaCEO, President, Compliance Officer & Director
- NRNeil R. CashmanCo-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
- LDLarry Douglas AltstielChief Medical Officer
- WWWilliam W. WymanIndependent Director
- JMJoshua Mandel-BrehmIndependent Director
